SIGNATUREFD, LLC - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 155 filers reported holding REVANCE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
SIGNATUREFD, LLC ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$9,612
-72.7%
838
-39.8%
0.00%
-100.0%
Q2 2023$35,257
-21.4%
1,3930.0%0.00%0.0%
Q1 2023$44,869
+1458.0%
1,393
+792.9%
0.00%
Q4 2022$2,880
-58.9%
156
-36.8%
0.00%
Q3 2022$7,000
+250.0%
247
+126.6%
0.00%
Q2 2022$2,0000.0%109
+28.2%
0.00%
Q1 2022$2,000
-66.7%
85
-76.4%
0.00%
Q4 2021$6,000
+200.0%
360
+445.5%
0.00%
Q3 2021$2,0000.0%66
-18.5%
0.00%
Q2 2021$2,0000.0%81
+22.7%
0.00%
Q1 2021$2,0000.0%660.0%0.00%
Q4 2020$2,0000.0%660.0%0.00%
Q3 2020$2,0000.0%660.0%0.00%
Q2 2020$2,000
+100.0%
660.0%0.00%
Q1 2020$1,0000.0%660.0%0.00%
Q4 2019$1,0000.0%660.0%0.00%
Q3 2019$1,0000.0%660.0%0.00%
Q2 2019$1,000660.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 3,342,047$52,671,00026.22%
NovaQuest Capital Management, L.L.C. 1,558,426$24,561,00022.85%
Sio Capital Management, LLC 254,581$4,012,0001.08%
ArrowMark Colorado Holdings LLC 3,409,217$53,729,0000.51%
Fosun International Ltd 472,532$7,447,0000.47%
Rhenman & Partners Asset Management AB 193,181$3,045,0000.36%
Phoenix Investment Adviser LLC 4,900$77,0000.17%
HARBOURVEST PARTNERS LLC 26,565$419,0000.15%
Quinn Opportunity Partners LLC 56,672$893,0000.12%
MFN Partners Management, LP 46,000$725,0000.12%
View complete list of REVANCE THERAPEUTICS INC shareholders